3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy: Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of '3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy: Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial'. Together they form a unique fingerprint.